CYFRA 21-1 levels in cerebrospinal fluid as a putative therapeutic monitoring biomarker for patients with leptomeningeal carcinomatosis: A pilot study-Reference-Cited by-同舟云学术

CYFRA 21-1 levels in cerebrospinal fluid as a putative therapeutic monitoring biomarker for patients with leptomeningeal carcinomatosis: A pilot study

Published:2020-04-30 Issue:1 Volume:28 Page:81-89
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Hyun Jae-Won¹,Shin Hyung Shik²,Kim Su-Hyun¹,Kong Sun-Young²,Yoo Heon³,Gwak Ho-Shin³,Kim Ho Jin¹

Affiliation:

1. Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea

2. Department of Laboratory Medicine, Research Institute and Hospital of National Cancer Center, Goyang, Korea

3. Department of Neurosurgery, Research Institute and Hospital of National Cancer Center, Goyang, Korea

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference20 articles.

1. Clinical utility of cytokeratins as tumor markers;Barak;Clin Biochem,2004

2. Evaluation of tissue polypeptide specific antigen, CYFRA 21-1 and carcinoembryonic antigen in non small cell lung carcinoma: Does the combined use of cytokeratin markers give an additional information;Nisman;Cancer,1998

3. Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung;Park;Lung Cancer,2013

4. Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer;Boeck;Br J Cancer,2013

5. Survival of breast cancer patients with meningeal carcinomatosis;Gauthier;Ann Oncol,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?;Expert Review of Neurotherapeutics;2023-12-25

2. CoNi-RGO and NiCo2S4-ZIF/g-C3N4 signal amplified electrochemical immunosensors for sensitive detection of CYFRA 21-1;Analytical Biochemistry;2022-12

3. The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer;Journal of Cancer Research and Clinical Oncology;2022-05-18

4. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma—What Do We Already Know;Cancers;2022-03-15

5. Exploratory Profiling of Extracellular MicroRNAs in Cerebrospinal Fluid Comparing Leptomeningeal Metastasis with Other Central Nervous System Tumor Statuses;Journal of Clinical Medicine;2021-10-22